Cavernous angioma epidemiology and demographics

Jump to navigation Jump to search

Cavernous angioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Cavernous angioma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

CT

MRI

MRA

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cavernous angioma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cavernous angioma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cavernous angioma epidemiology and demographics

CDC on Cavernous angioma epidemiology and demographics

Cavernous angioma epidemiology and demographics in the news

Blogs on Cavernous angioma epidemiology and demographics

Directions to Hospitals Treating Cavernous angioma

Risk calculators and risk factors for Cavernous angioma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.


Overview

Cavernous angioma is the second most common form of intravascular malformation next to the developmental venous anomaly (DVA). The incidence in the general population is between 0.1–0.5%, and symptoms usually manifest in the third to fifth decade of life. Once thought to be strictly congenital, these vascular lesions have been found to occur de novo.

Epidemiology

Incidence

Prevalence

Multiple Lesions

Age

Race

Gender

References

  1. 1.0 1.1 1.2 Idiculla PS, Gurala D, Philipose J, Rajdev K, Patibandla P (2020). "Cerebral Cavernous Malformations, Developmental Venous Anomaly, and Its Coexistence: A Review". Eur Neurol. 83 (4): 360–368. doi:10.1159/000508748. PMID 32731220 Check |pmid= value (help).
  2. 2.0 2.1 Zafar A, Quadri SA, Farooqui M, Ikram A, Robinson M, Hart BL; et al. (2019). "Familial Cerebral Cavernous Malformations". Stroke. 50 (5): 1294–1301. doi:10.1161/STROKEAHA.118.022314. PMC 6924279 Check |pmc= value (help). PMID 30909834.
  3. Choquet H, Nelson J, Pawlikowska L, McCulloch CE, Akers A, Baca B; et al. (2014). "Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation". Cerebrovasc Dis. 37 (1): 57–63. doi:10.1159/000356839. PMC 3995158. PMID 24401931.
  4. Rigamonti D, Hadley MN, Drayer BP, Johnson PC, Hoenig-Rigamonti K, Knight JT; et al. (1988). "Cerebral cavernous malformations. Incidence and familial occurrence". N Engl J Med. 319 (6): 343–7. doi:10.1056/NEJM198808113190605. PMID 3393196.
  5. Zabramski JM, Wascher TM, Spetzler RF, Johnson B, Golfinos J, Drayer BP; et al. (1994). "The natural history of familial cavernous malformations: results of an ongoing study". J Neurosurg. 80 (3): 422–32. doi:10.3171/jns.1994.80.3.0422. PMID 8113854.
  6. Flemming KD, Graff-Radford J, Aakre J, Kantarci K, Lanzino G, Brown RD; et al. (2017). "Population-Based Prevalence of Cerebral Cavernous Malformations in Older Adults: Mayo Clinic Study of Aging". JAMA Neurol. 74 (7): 801–805. doi:10.1001/jamaneurol.2017.0439. PMC 5647645. PMID 28492932.